期刊文献+

安肺益肾方对慢性阻塞性肺疾病大鼠肺组织匀浆IL-6、IL-8、TNF-α及SOD、MDA的作用 被引量:15

Effects of Anfei Yishen Formula on IL-6, IL-8, TNF-α and SOD, MDA in rats pulmonary tissue homogenate with chronic obstructive pulmonary disease
原文传递
导出
摘要 目的:探讨安肺益肾方对熏香烟加气管注内毒素法制造的慢性阻塞性肺疾病(COPD)模型大鼠肺组织匀浆炎性因子白细胞介素--6(IL-6)、IL-8、肿瘤坏死因子--α(TNF-α)的作用,以及抗氧化指标超氧化物歧化酶(SOD)、丙二醛(MDA)的作用。方法:熏香烟加气管注内毒素法建立COPD模型,实验设正常组,模型组,安肺益肾方大、中、小剂量组,氨茶碱组。连续给药4周后,取大鼠左上肺制成10%匀浆液,用Elisa法检测IL-6、IL-8、TNF-α、SOD、MDA含量。结果:与正常组比较,模型组肺组织匀浆中IL-6、IL-8、TNF-α、MDA含量增加,SOD含量降低(P<0.001),安肺益肾方能降低模型大鼠肺组织匀浆中IL-6、IL-8、TNF-α、MDA含量(P<0.05,P<0.01,P<0.001),增加SOD含量(P<0.05)。结论:安肺益肾方对COPD模型大鼠有一定抗炎、抗氧化的作用。 Objective: To investigate the effects of Anfei Yishen Formula (AFYSF) on IL-6, IL-8, TNF-a, SOD, MDA of rats pulmonary tissue homogenate with chronic obstructive pulmonary disease (COPD) induced by intratracheal instillation of lipopolysaccharide and passive smoking. Methods: The rat models with COPD were induced by intratracheal instillation of lipopolysaccharide and passive smoking, except normal control group. 72 Wistar rats were divided into AFYSF high, middle, small dose group, aminophylline group, model group, and normal group by a randomized single blind method. The left upper lung of rat was made into 10% homogenate, then the IL-6, IL-8, TNF-a, SOD, MDA levels in the 10% homogenate were tested by Elisa after four weeks' treatment. Results: Compared with the normal group, the IL-6, IL8 TNF-a, MDA levels in the model group were increased (P〈0.001), the SOD level was decreased (P〈0.001). AFYSF can reduce the expression of inflammatory factors in rats pulmonary tissue homogenate with COPD induced by intratracheal instillation of lipopolysaccharide and passive smoking (P〈0.05, P〈0.01, P〈0.001); AFYSF can increase SOD level and decrease MDA level in rats pulmonary tissue homogenate (P〈0.05). Conclusion: AFYSF had anti-inflammatory and antioxidant effects in rats with COPD.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2013年第10期3092-3095,共4页 China Journal of Traditional Chinese Medicine and Pharmacy
关键词 安肺益肾方 慢性阻塞性肺疾病 炎性因子 氧化 抗氧化 Anfei Yishen Formula COPD Inflammatory factor Oxidant/Antioxidant
  • 相关文献

参考文献15

二级参考文献28

  • 1庞宝森,李远红,张洪玉.慢性阻塞性肺疾病动物模型的研究进展[J].心肺血管病杂志,2005,24(1):45-46. 被引量:12
  • 2庞宝森,李远红,张洪玉.慢性阻塞性肺疾病动物模型的研究进展(续)[J].心肺血管病杂志,2005,24(2):117-119. 被引量:3
  • 3Keatings VM,Collins PD,Seott DM, et al. Differences in interleukin-8 and tumor necrosis factor-u in induced sputum from patients with chronic obstructive pulmonary disease or asthma[J]. Am J Respir Crit Care Med. 1996,153(2) :530-534.
  • 4Thompson AB, Daughton D, Robbins RA, et al. Intraluminal airway inflammation in chronic bronchitis [ J ]. Am Rev Respir Dis, 1989, 140(6): 1527-1537.
  • 5Linden M, Rasmussen JB, Piitulainen E, et al. Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis[ J]. Am Rev Respir Dis, 1993,148(5) : 1226-1232.
  • 6Lacoste JY, Bousquet J, Chanez P, et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis ,and chronic obstructive pulmonary disease[J] .J Allergy Clin Immunol, 1993,92(4) :537-548.
  • 7Di Stefano A, Maestrelli P, Roggeri A, et al. Upregulation of adhesion molecules in the bronchial mucesa of subjects with chronic obstructive bronchitis[J] .Am J Respir Crit Care Med, 1994,149(3) :803-810.
  • 8Ollerenshaw SL, Woolcock AJ. Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation[J].Am Rev Respir Dis, 1992,145(4) :922-927.
  • 9Saetta M, Di Stefano A, Maestrelli P, et al. Activated T lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis[ J]. Am Rev Respir Dis, 1993,147(2) :301-306.
  • 10Grashoff WF, Sont JK, Sterk PJ, et al. Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages[ J ]. Am J Pathol, 1997,151 (6) : 1785-1790.

共引文献92

同被引文献222

引证文献15

二级引证文献244

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部